Research

Mifepristone
First Opinion

FDA shouldn’t allow politics to hurt women suffering miscarriage

By Dorothy Novick

Elderly Immunotherapy
First Opinion

We need more answers about immunotherapy for the elderly

By Ankur Parikh

Rolle Blood Vessel 02
In the Lab

‘Living Legos’ form blood vessels to simulate heart disease and test drugs

By Elizabeth Cooney

Health

Can this doctor figure out how to stop Alzheimer’s before it starts?

By Joshua Kendall

IV Drip Patient Safety
First Opinion

A new approach can take patient safety to the next level

By Jenna Merandi and Thomas Bartman

Leon Peshkin 02
In the Lab

An anti-aging researcher faces the loss of his inspiration: his 96-year-old father

By Karen Weintraub

In the Lab

Archived chat: last week in CRISPR — cancer, patents, and a dip in the market

By Sharon Begley

In the Lab

Synthesizing genetic sequences could get faster, one DNA letter at a time

By Karen Weintraub

Health

Controversial NIH study of ‘moderate drinking’ will be terminated after scathing report

By Sharon Begley and Andrew Joseph

Cellular Authophagy
Business

Is it time to target autophagy to treat disease? 

By Elizabeth Cooney

Women Clinical Trial
First Opinion

Studying sex differences will improve health for women and men

By Amy M. Miller and Rebecca Nebel

FDA campus
Pharmalot

The trouble with those post-marketing studies required by the FDA

By Ed Silverman

Pharmalot

Pharmalittle: Another Alzheimer’s drug failure; HHS wants pharma to voluntarily lower prices

By Ed Silverman

Exclusive

Alcohol study failed to seek FDA approval, possibly violating federal rules

By Sharon Begley

Clinical trials results for patients
Pharmalot

Clinical trial participants may not trust pharma, but they’re willing to share their data, anyway

By Ed Silverman

In the Lab

A serious new hurdle for CRISPR: Edited cells might cause cancer, two studies find

By Sharon Begley

In the Lab

Drones are helping researchers figure out what viruses live in whales. Some are similar to ones in humans

By Megha Satyanarayana

Bubonic Plague Burial
In the Lab

A set of ancient teeth unlock a bacterial secret about the bubonic plague

By Ike Swetlitz

premature pregnancy test
In the Lab

Blood test might help predict both preterm and healthy delivery dates

By Karen Weintraub

Biotech

The Gates Foundation rolls out details of its new biotech, one without a profit motive

By Helen Branswell

Speeding Up Development
First Opinion

30 years is too long to wait for new medicines. There are ways to speed up drug development

By Fred D. Ledley

First Opinion

The ‘cruel joke’ of compassionate use and right to try: Pharma companies don’t have to comply

By Vibhav Rangarajan

In the Lab

What we heard at CRISPRCon: talk of designer babies, IP battles, and scientific colonialism

By Damian Garde

Breast Cancer Cells
In the Lab

From one breast cancer patient’s turnaround, clues to a new immunotherapy

By Sharon Begley

Health

Many breast cancer patients can skip chemo, big study finds

By Associated Press

Stem Cell Storage
Health

Stem cell bank opens with backing from leading scientists. Is it worth the money?

By Andrew Joseph

DNA Donors
First Opinion

DNA donors must demand stronger protection for genetic privacy

By Mason Marks and Tiffany Li

In the Lab

Shot through with microbes: How our bodies adapt to a hidden world of bacteria

By Carl Zimmer

Multiple Myeloma 01
Health

Once quickly lethal and still humbling, multiple myeloma may be in a ‘golden age’ of treatment

By Karen Weintraub

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy